RLMD stock

Relmada Therapeutics Inc (RLMD) EPS is -$1.09

Relmada Therapeutics Inc (RLMD) EPS is -$1.09. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.

Read the full RLMD research page for quote, filings, and the rest of the model. This satellite exists so “Relmada Therapeutics Inc EPS” can rank with the actual number, then send you to /stock/rlmd.

Full RLMD analysis